| Structure |
Chemical Name |
CAS |
MF |
 |
1-(4-(2-Methoxyethyl)phenoxy)-3-(oxiran-2-ylMethoxy)propan-2-ol |
1416440-64-6 |
C15H22O5 |
 |
(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine |
1354621-59-2 |
C14H22N2 |
![6-acetyl-2-aMino-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one](/CAS/GIF/571189-64-5.gif) |
6-acetyl-2-aMino-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one |
571189-64-5 |
C15H18N4O2 |
![IMp. C (EP): Ethyl [(4-Methylphenyl)sulphonyl]-CarbaMate](/) |
IMp. C (EP): Ethyl [(4-Methylphenyl)sulphonyl]-CarbaMate |
|
|
|
|
IMp. C (EP): Methyl-2-[4-[2-[(4-Chlorobenzoyl)aMino]ethyl]phenoxy]-2-Methylpropanoate |
|
|
 |
5-PyriMidinecarboxylic acid, 4-(4-fluorophenyl)-1,2-dihydro-6-(1-Methylethyl)-2-oxo-, Methyl ester |
488798-37-4 |
C15H15FN2O3 |
 |
Isotachysterol3 |
22350-43-2 |
C27H44O |
 |
Nitrendipine Propyl Ester |
225785-54-6 |
C19H22N2O6 |
 |
O-DesMethyl Urapidil |
91453-03-1 |
C19H27N5O3 |
 |
(1R,3R,4R)-Entecavir |
1367369-76-3 |
C12H15N5O3 |
![5-(5-chloro-1-(2-fluorophenyl)-2-oxopentyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate](/CAS/20150408/GIF/1056459-37-0.gif) |
5-(5-chloro-1-(2-fluorophenyl)-2-oxopentyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate |
1056459-37-0 |
C20H21ClFNO3S |
 |
Linagliptin iMpurity |
2140263-92-7 |
C25H28N8O2 |
![1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxaMide](/CAS/20150408/GIF/256376-62-2.gif) |
1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxaMide |
256376-62-2 |
C14H11FN4O |
 |
cefaclor iMpurity H |
|
C4H6N4O3S2 |
|
|
Tadalafil iMpurity E |
|
|
 |
3,3',5-TRIIODOTHYROPROPIONIC ACID |
51-26-3 |
C15H11I3O4 |
 |
Cytidine,N-benzoyl-2^-C-Methyl-,3^,5^-dibenzoate(9CI) |
863329-64-0 |
C31H27N3O8 |
 |
1-Pyrrolidinecarboxylic acid, 4-oxo-2-(3-thiazolidinylcarbonyl)-, 1,1-diMethylethyl ester, (2R)- |
1415908-67-6 |
C13H20N2O4S |
 |
FaMotidine iMpurity |
130463-35-3 |
C5H8N4S2.Na |
|
|
Nitrendipine iMpurity |
|
|
 |
TraMadol EP IMpurity-C |
66170-31-8 |
C16H24ClNO |
|
|
ChlorphenaMine IMpurity B |
|
|
 |
Clozapine EP IMpurity D |
65514-71-8 |
C18H21ClN4O |
|
|
Febuxostat IMpurity (2-(3-carboxy-4-isobutyloxyphenyl)-4-Methylthiazole-5-carboxylic acid) |
|
|
 |
Fluconazole IMpurity I |
|
C13H12F2N6O |
 |
IMidafenacin Related CoMpound 1 (4-(1H-IMidzol-1-yl)-2,2-DiphenylbutanaMide) |
170105-20-1 |
C19H19N3O |
 |
IMidafenacin Related CoMpound 6 (4-AcetiMidoylaMino-2,2-DiphenylbutanaMide) |
503598-33-2 |
C18H21N3O |
 |
Lansoprazole IMpurity H |
1346598-28-4 |
C23H16F3N5OS |
 |
LevetiracetaM IMurity (L-2-AMinobutanaMide HCl,S-2-AMinobutanaMide HCl) |
1933471-30-7 |
C8H14N2O3 |
|
|
Milrinone IMpurity 4 |
|
|
|
|
Nebivolol O-Beta-D-Glucuronide |
|
|
|
|
Nicergoline IMp. C (EP) |
|
|
|
|
Perindopril IMpurity E |
|
|
 |
Pitavastatin 3-Oxo SodiuM |
2245811-12-3 |
C25H22FNO4 |
 |
PraMipexole IMp.BI-II828BS |
|
C20H32N6S2 |
|
|
Propofol IMpurity F |
|
|
 |
Sertraline IMpurity (SRTRC-3) |
|
C17H17Cl2N |
 |
Terbutaline IMpurity B |
94120-05-5 |
C13H19NO3 |
![Benzoic acid, 4-[(4-Methyl-1-piperazinyl)Methyl]-3-(trifluoroMethyl)-](/CAS/20150408/GIF/859282-11-4.gif) |
Benzoic acid, 4-[(4-Methyl-1-piperazinyl)Methyl]-3-(trifluoroMethyl)- |
859282-11-4 |
C14H17F3N2O2 |
 |
5-chloro-2,3-diphenylpyrazine |
41270-66-0 |
C16H11ClN2 |
|
|
Canagliflozin iMpurity |
|
|
 |
Vortioxetine iMpurity |
853745-55-8 |
C10H14BrClN2 |
 |
PD 312236 |
501666-24-6 |
C20H35NO11 |
![(17α)-3,3-[1,2-Ethanediylbis(oxy)]-17-hydroxy-19-norpregna-5(10),9(11)-diene-21-nitrile](/CAS/GIF/190662-30-7.gif) |
(17α)-3,3-[1,2-Ethanediylbis(oxy)]-17-hydroxy-19-norpregna-5(10),9(11)-diene-21-nitrile |
190662-30-7 |
C22H29NO3 |
 |
(S)-4-(4-Hydrazinobenzyl)-2-oxazolidinone Hydrochloride |
139264-57-6 |
C10H14ClN3O2 |
![1-[4-(4-AMino-6,7-diMethoxy-2-quinazolinyl)-1-piperazinyl]-5-hydroxy-1-pentanone](/CAS/GIF/109678-71-9.gif) |
1-[4-(4-AMino-6,7-diMethoxy-2-quinazolinyl)-1-piperazinyl]-5-hydroxy-1-pentanone |
109678-71-9 |
C19H27N5O4 |
![4-[2-(2-AMino-4,5,6,7-tetrahydro-4,6-dioxo-3H-pyrrolo[2,3-d]pyriMidin-5-yl)ethyl]benzoic Acid](/CAS/GIF/193265-47-3.gif) |
4-[2-(2-AMino-4,5,6,7-tetrahydro-4,6-dioxo-3H-pyrrolo[2,3-d]pyriMidin-5-yl)ethyl]benzoic Acid |
193265-47-3 |
C15H14N4O4 |
 |
9-(1,3-Dioxolan-2-ylMethyl)-3,9-dihydro-1,3-diMethyl-1H-purine-2,6-dione |
1174289-18-9 |
C11H14N4O4 |
 |
DesMethyl AMisulpride |
148516-54-5 |
C16H25N3O4S |
 |
DiMethoxy Dienogest |
102193-41-9 |
C22H31NO3 |
 |
Desfluoro Rosuvastatin Sodium Salt |
847849-66-5 |
C22H29N3O6S |
![N-Benzoyl-N-[2-(phenyl)ethyl]-N-carbamic Acid R-Quinuclidinol Ester Succinic Acid Salt](/CAS/20140608/GIF/CB12701784.gif) |
N-Benzoyl-N-[2-(phenyl)ethyl]-N-carbamic Acid R-Quinuclidinol Ester Succinic Acid Salt |
1798817-92-1 |
C27H32N2O7 |
|
|
Tadalafil EP IMpurity A |
|
|
 |
(1R,3R,4R)-3-AMino-4-hydroxy-cyclohexanecarboxylic acid ethyl ester |
1392745-70-8 |
C14H25NO5 |
 |
(S)-3-Hydroxypiperidine |
24211-55-0 |
C5H11NO |
 |
EzetiMibe ring-opening dehydrate iMpurity |
1292292-63-7 |
C24H21F2NO3 |
 |
Fondaparinux sodiuM iMpurity 1 |
348625-84-3 |
C13H21NO19S3 |
 |
Pitavastatin IMpurity 4 (PP-4) |
1422058-54-5 |
C25H22FNO3 |
 |
Pregabalin IMpurity |
159029-27-3 |
C7H18N2 |
 |
Valdecoxib 3'-SulfonaMide IMpurity |
1373038-56-2 |
C16H14N2O3S |
 |
(3R,4R)-4-(2,5-Difluorophenyl)-3-Methyl-4-(1H-1,2,4-triazol-1-ylMethyl)-2-oxetanone |
483340-20-1 |
C13H11F2N3O2 |
 |
6,7-DiMethoxy-2-(4-(tetrahydrofuran-2-carbonyl)piperazin-1-yl)quinazolin-4(1H)-one |
1177261-73-2 |
C19H24N4O5 |
![13-oxo-1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid](/CAS/20150408/GIF/229312-33-8.gif) |
13-oxo-1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid |
229312-33-8 |
C13H22N4O5 |
 |
rac-Clopidogrel Carboxylic Acid Hydrochloride |
1015247-88-7 |
C15H15Cl2NO2S |
 |
Milnacipran IMpurity |
810696-16-3 |
C11H11NO |
 |
Terbutaline IMpurity 8 |
28924-20-1 |
C26H30BrNO3 |
 |
Etoricoxib IMpurity |
1350206-14-2 |
C18H16N2O2S |
![(1R,2R,4S)-2-[(tert-butoxycarbonyl)aMino]-4-[(diMethylaMino)carbonyl]cyclohexyl Methanesulfonate](/CAS/20150408/GIF/929693-31-2.gif) |
(1R,2R,4S)-2-[(tert-butoxycarbonyl)aMino]-4-[(diMethylaMino)carbonyl]cyclohexyl Methanesulfonate |
929693-31-2 |
C15H28N2O6S |
 |
7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carboxaMide |
417724-81-3 |
C11H10N2O3 |
|
|
Tegafur Impurity BCB |
|
|
 |
((2R,3R,4R)-3-(benzoyloxy)-4-chloro-4-Methyl-5-oxotetrahydrofuran-2-yl)Methyl benzoate |
1496551-65-5 |
C20H17ClO6 |
 |
2-(4-fluorophenyl)-5-(2-Methylbenzyl)thiophene |
2005454-69-1 |
C18H15FS |
![AcetaMide, N-[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]-](/CAS/20150408/GIF/1429334-00-8.gif) |
AcetaMide, N-[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]- |
1429334-00-8 |
C16H19N3O5 |
 |
PSI 7411 |
1015073-43-4 |
C10H14FN2O8P |
![5-[[4-(Hydroxymethyl)phenoxy]methyl]-3-(1-methylethyl)-2-oxazolidinone](/CAS/20150408/GIF/1071765-44-0.gif) |
5-[[4-(Hydroxymethyl)phenoxy]methyl]-3-(1-methylethyl)-2-oxazolidinone |
1071765-44-0 |
C14H19NO4 |
![(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol 2,3,4,6-tetrakis(2,2-dimethylpropanoate)](/CAS/20180906/GIF/1283129-18-9.gif) |
(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol 2,3,4,6-tetrakis(2,2-dimethylpropanoate) |
1283129-18-9 |
C44H57FO9S |
![[1,4'-Bipiperidine]-1'-carboxylic acid](/CAS/20150408/GIF/1026078-50-1.gif) |
[1,4'-Bipiperidine]-1'-carboxylic acid |
1026078-50-1 |
C11H20N2O2 |
![4-[[3-(1-Methylethyl)-2-oxo-5-oxazolidinyl]methoxy]benzaldehyde](/CAS/20150408/GIF/1173203-26-3.gif) |
4-[[3-(1-Methylethyl)-2-oxo-5-oxazolidinyl]methoxy]benzaldehyde |
1173203-26-3 |
C14H17NO4 |
|
|
EMpagliflozin iMpurity 9 |
|
|
 |
EMpagliflozin iMpurity 14 |
2137418-13-2 |
C23H27ClO8 |
|
|
ibrutinib iMpurity A |
|
|
|
|
Sunitinib iMpurity E |
|
|
 |
Rosuvastatin EP impurity H |
1335110-44-5 |
C22H28FN3O6S |
|
|
Saxagliptin Impurity 4 (Deoxy Saxagliptin) |
|
|
 |
Betamethasone EP Impurity D |
52619-05-3 |
C25H33FO7 |
 |
Dihydropenicillin F Potassium Salt |
31447-86-6 |
C14H23KN2O4S |
 |
Etoricoxib Impurity 7 |
646459-39-4 |
C20H21N3O2S |
 |
Mupirocin Impurity D |
|
C26H44O9 |
 |
Phenylephrine EP Impurity D |
1367567-95-0 |
C16H19NO2 |
 |
Verapamil Impurity O |
959011-16-6 |
C27H38N2O4 |
![1,1′-[(1-Methylethyl)imino]bis[3-[4-(2-methoxyethyl)phenoxy]-2-propanol hydrochloride](/CAS/20211123/GIF/1486464-40-7.gif) |
1,1′-[(1-Methylethyl)imino]bis[3-[4-(2-methoxyethyl)phenoxy]-2-propanol hydrochloride |
1486464-40-7 |
C27H42ClNO6 |
 |
4'-FLUOROCYCLOPROPANECARBOXANILIDE |
2354-89-4 |
C10H10FNO |
 |
(Z)-2-(2-Aminothiazol-4-yl)-2-(1-carboxy-1-methyl)ethoxyiminoacetic acid |
102507-85-7 |
C9H11N3O5S |
|
|
Cefaclor EP IMpurity |
|
|
 |
Linagliptin Impurity F |
1673546-62-7 |
C27H27F3N8O3 |
|
|
Parecoxib Impurity D |
|
|
|
|
Parecoxib Impurity I |
|
|
 |
Lenvatinib Impurity d |
417717-04-5 |
C20H17ClN4O4 |
 |
4-bromo-3-(hydroxymethyl)phenol |
2737-20-4 |
C7H7BrO2 |
 |
4-(4-Bromo-3-formyl-phenoxy)-benzonitrile |
906673-54-9 |
C14H8BrNO2 |